Michael Cerra
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Kevin CamphausenWilliam BurganPhilip J. TofilonKelli OswaldDavid CernaJeffery S. RussellJane B. TrepelMin-Jung Lee
- Journals
- Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)European Heart Journal (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Michael Cerra
13 papers receiving 892 citations
Peers
Comparison fields: 5 of 65
- Genetics 180
- Hematology 123
- Molecular Biology 647
- Internal Medicine 33
- Oncology 217
Countries citing papers authored by Michael Cerra
This map shows the geographic impact of Michael Cerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cerra more than expected).
Fields of papers citing papers by Michael Cerra
This network shows the impact of papers produced by Michael Cerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cerra. The network helps show where Michael Cerra may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Cerra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 69 | |
| 2 | 2020 | 2 | |
| 3 | 2017 | 78 | |
| 4 | 2014 | 11 | |
| 5 | The effects of simvastatin on the pharmacokinectics of sitagliptin. | 2012 | 8 |
| 6 | 2005 | 80 | |
| 7 | 2004 | 169 | |
| 8 | 2004 | 27 | |
| 9 | 2004 | 81 | |
| 10 | Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci. | 2004 | 35 |
| 11 | 2004 | 29 | |
| 12 | 2004 | 183 | |
| 13 | Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. | 2003 | 137 |
About Michael Cerra
Michael Cerra is a scholar working on Hematology, Cancer Research, Genetics, Hepatology and Molecular Biology, having authored 13 papers that have together received 909 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), Epigenetics and DNA Methylation (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Genetics (180 citations), Hematology (123 citations), Molecular Biology (647 citations), Internal Medicine (33 citations) and Oncology (217 citations). Michael Cerra has collaborated with scholars based in United States and Germany. Frequent co-authors include Kevin Camphausen, William Burgan, Philip J. Tofilon, Kelli Oswald, David Cerna, Jeffery S. Russell, Jane B. Trepel, Min-Jung Lee, Mary Sproull and Howard A. Fine. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Arteriosclerosis Thrombosis and Vascular Biology, European Heart Journal and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.